Log in

Relevant bibliographies by topics / HCV / Books

To see the other types of publications on this topic, follow the link: HCV.

Books on the topic 'HCV'

Author: Grafiati

Published: 4 June 2021

Last updated: 6 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'HCV.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. New York: Community Prescription Service, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dammacco, Franco, ed. HCV Infection and Cryoglobulinemia. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-1705-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Milano: Springer-Verlag Italia, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Musharraf, Husain, and Population Council (Bangladesh), eds. Prevalence of HIV, HBV, HCV and syphilis markers in pregnant women of Bangladesh. Dhaka, Bangladesh: Population Council, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Okita, Kiwamu, ed. HCV and Related Liver Diseases. Tokyo: Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-68488-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jürgens, Ralf. HIV/AIDS and HCV in prisons: A select annotated bibliography. Ottawa, Ont: International Affairs Directorate, Health Canada, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Okita, Kiwamu, ed. HCV/Oxidative Stress and Liver Disease. Tokyo: Springer Japan, 2003. http://dx.doi.org/10.1007/978-4-431-67005-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kiwamu, Okita, ed. HCV/oxidative stress and liver disease. Tokyo: Springer, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

name, No. HCV/oxidative stress and liver disease. Tokyo: Springer, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sofia, Michael J., ed. HCV: The Journey from Discovery to a Cure. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28400-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Sofia, Michael J., ed. HCV: The Journey from Discovery to a Cure. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28207-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Dirgahayu, Paramasari. Molecular epidemiology database of HIV, HBV, HCV, HDV, HTLV-1/2, and TTV in Central of Java, Indonesia: Final report international research collaboration and international publication. [Surakarta]: Sebelas Maret Univ., 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Association, Canadian Hospital, ed. Guide to policies for health care facilities and agencies: Bloodborne pathogens, especially Human Immunodeficiency Virus (HIV), Hepatitis B Virus, (HBV) and Hepatitis C Virus (HCV). Ottawa, Ont: Canadian Hospital Association, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

G, Gish Robert, ed. Maximizing the benefits of antiviral therapy for HCV: The advantages of treating side effects. Philadelphia: W.B. Saunders, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Duncan, Tim. Conquering Hepatitis C and surviving treatment: An essential guide through every step of the HCV treatment process. [Place of publication not identified]: T. Duncan, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Giulio, Pisani, ed. Nucleic acid amplification technology (NAT) for the detection of Hepatitis C Virus (HCV) in plasma pools: Validation report. Roma: Istituto superiore di sanità, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Mohamed Hatem Fathi El-Saied Wali. Natural history, factors affecting severity and progression rate of hepatitis c virus (HCV) infection in liver transplanted and non-transplanted patients. Birmingham: University of Birmingham, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Seminario, di aggiornamento sull'epatite da HCV: diagnosi epidemiologia prevenzione e. terapia (4th 1997 Rome Italy). IV Seminario di aggiornamento sull'epatite da HCV: Diagnosi, epidemiologia, prevenzione e terapia : Istituto superiore di sanità, Roma, 3-4 novembre 1997 : atti. Roma: Istituto superiore di sanità, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Käser, Elke Beatrice. Der Hallesche HCV-Impfschadensfall 1978/79 und die Verantwortung der Bundesrepublik Deutschland: Gleichzeitig ein Beitrag zu intertemporalkollisionsrechtlichen Fragestellungen auf einfachgesetzlicher und verfassungsrechtlicher Ebene. Leipzig: Leipziger Universitätsverlag, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Seminario, di aggiornamento sull'epatite da virus HCV e. nuovi virus potenzialmente epatitici: diagnosi epidemiologia prevenzione e. terapia (5th 2000 Rome Italy). V Seminario di aggiornamento sull'epatite da virus HCV e nuovi virus potenzialmente epatitici: Diagnosi, epidemiologia, prevenzione e terapia : Istituto superiore di sanità, Roma, 20-21 dicembre 2000 : atti. Roma: Istituto superiore di sanità, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Corporation, International Business Machines, ed. I/O configuration using z/OS HCD and HCM. [S.l.]: Vervante, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Administration, United States Occupational Safety and Health. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Washington, D.C: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). [Washington, D.C.?: U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Kumar, Rajendra. HCI Human Computer Interaction: HCI. 2nd ed. India: Laxmi Publications, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Wilson, Deanna. Hepatitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0035.

Full text

Abstract:

Hepatitis A (HAV) and E (HEV) viruses are spread via the fecal-oral route. Hepatitis B virus (HBV) exposure is via occupational or recreational activities. Hepatitis D virus (HDV; also spread parentally) can only coinfect or superinfect those with chronic HBV. Hepatitis C (HCV) transmission is predominantly parenteral; the highest risk group is injection drug users. Prodromal-period patients with acute hepatitis present with vague constitutional symptoms when serum transaminases peak, with elevated serum bilirubin and varying levels of hepatic protein synthesis impairment; during the icteric phase, patients develop abdominal pain, hepatomegaly, and jaundice. Acute hepatitis has limited therapy; treatment is predominantly supportive. However, most adults with acute phase HAV, HBV, HDV, and HEV spontaneously clear the virus. Most individuals with HCV develop chronic hepatitis. Patients with known HAV, HBV, or HEV exposures may be eligible for post-exposure prophylaxis to reduce their risk of infection.

APA, Harvard, Vancouver, ISO, and other styles

27

Keshav, Satish, and Palak Trivedi. Viral hepatitis. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0212.

Full text

Abstract:

Hepatitis means ‘inflammation of the liver’ and is manifest with symptoms that include malaise, anorexia, fever, flu-like symptoms, and pain in the right upper quadrant of the abdomen, with the pain being caused by swelling of the liver and its capsule. Elevations in circulating hepatic enzymes, particularly aspartate transaminase and alanine transaminase, are common, with jaundice occurring some time after the onset of other symptoms and signs. There are five viruses that primarily cause viral hepatitis: hepatitis A, B, C, D, and E viruses, abbreviated HAV, HBV, HCV, HDV, and HEV, respectively. These viruses are all hepatotrophic, in that the liver is the primary site of infection. HAV, HBV, and HEV are usually acute, self-limiting infections that may, nonetheless, cause morbidity and, in the case of HEV, fatality. However, HBV and, more so, HCV can cause chronic carriage of the virus over many years, as well as the development of chronic hepatitis. HDV is only pathogenic in conjunction with HBV. After recovery from acute infection with HAV, individuals have long-lasting immunity against further infection. The same holds true for the majority of individuals with acute HBV infection. There seems to be little natural immunity to HCV infection, and a significant proportion of cases result in chronic hepatitis. Immunity to HEV is not long-lasting, and repeated infections are possible. Many other viruses can cause hepatitis, of which cytomegalovirus, herpes simplex virus, Epstein–Barr virus, and flaviviruses such as dengue and yellow fever are the most important. The liver, however, is not their primary site of replication or cellular damage.

APA, Harvard, Vancouver, ISO, and other styles

28

HCV Testing. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Decision-Making in HIV/HCV Co-Infection. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Price, Jennifer Cohen, Priyanka Amin, and Antoine Douaihy. Hepatitis C and HIV Co-Infection. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0043.

Full text

Abstract:

Chronic infection with hepatitis C virus (HCV) is a leading cause of end-stage liver disease and is the most common indication for liver transplantation in the United States. Because of shared risk factors, individuals living with HIV infection are disproportionately affected by HCV. Moreover, co-infection with HIV accelerates the natural history of chronic HCV infection, increasing the risk of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and death. Highly effective medications such as direct-acting antivirals (DAA) to cure HCV are now available and have the potential to profoundly improve the health of HIV-HCV-co-infected individuals. However, addressing the many gaps in the HCV care cascade is necessary to fully achieve the benefits of these drugs. This chapter reviews the natural history of HIV-HCV co-infection, the psychiatric comorbidities associated with HCV infection, the evolution of HCV treatment, and the barriers to care that HIV-HCV-co-infected individuals continue to face.

APA, Harvard, Vancouver, ISO, and other styles

31

Ashm. Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Preventing HCV in Scotland. NHS Health Scotland, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Dammacco, Franco. HCV Infection and Cryoglobulinemia. Springer, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Decision Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Decision Making in Hcv. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Decision-Making in HCV. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

HIV, STIs, HEPATITIS B (HBV) and HEPATITIS C (HCV) ISSUES for MEDICARE LOCALS. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Decision Making in HCV (Canada). Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

HCV and Related Liver Diseases. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Okita, Kiwamu. HCV and Related Liver Diseases. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Hcv Treatments Quick Reference Tool. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Decision-Making in Hcv ¿ Portugal. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Okita, Kiwamu. HCV and Related Liver Diseases. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

HCV Treatment Quick Reference Tool. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Hsieh, Meng-Tien. HBV- and HCV-related hepatocarcinogenesis: Mechanisms and implication of treatment. 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Decision-Making in Hcv in Chicago. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Okita, K. HCV/Oxidative Stress and Liver Disease. Springer London, Limited, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

HCV TREATMENTS QUICK REFERENCE TOOL (Canada). Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Okita, K. Hcv/Oxidative Stress and Liver Disease. Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!